[Safety of medications derived from blood vis-a-vis new infectious agents].
Piotrowicz-Theizen
D
D
Laboratoire LFB, Courtaboeuf, France. Dominique.piotrowicz@zlbbehring.com
D001688:Biological Products / Q000592:standards*; D001769:Blood; D017848:Blood-Borne Pathogens / Q000302:isolation & purification; D007562:Creutzfeldt-Jakob Syndrome / Q000517:prevention & control / Q000635:transmission; D005602:France; D006801:Humans; D007391:International Cooperation; D011328:Prions / Q000302:isolation & purification; D012449:Safety / Q000331:legislation & jurisprudence / Q000592:standards*; D017751:Safety Management / Q000331:legislation & jurisprudence / Q000379:methods / Q000592:standards; D014901:West Nile Fever / Q000517:prevention & control / Q000635:transmission; D014902:West Nile virus / Q000302:isolation & purification
D001688:Biological Products; D011328:Prions